CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES - France 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:400-500
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:800-900
Total Number of Projects:68
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:400-500
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:900-1000
Project Leadership Index:900-1000
Diversity Index:800-900
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Total Project Funding:400-500
Networking Rank (Reputation):900-1000
Partner Constancy:800-900
Project Leadership Index:800-900
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 13
As coordinator: 1
As participant: 12
Sole participant: 0
Coordinator / Participant Ratio: 0.08*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 6.334.804 453.595 1
2020 9.996.350 0 3.642.770 1
2019 0 13.137.396 5.000 1
2018 0 12.591.211 1.027.148 2
2017 0 5.555.836 375.125 1
2015 0 5.425.113 345.281 1
2013 0 5.996.971 461.305 1
2012 0 11.947.742 848.512 3
2010 0 22.771.541 777.892 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
INSTITUT CATALA DE LA SALUT3
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA2
ETABLISSEMENT FRANCAIS DU SANG2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
HOSPITAL CLINIC DE BARCELONA2
KING'S COLLEGE LONDON2
KLINIKUM DER UNIVERSITAET REGENSBURG2
NANTES UNIVERSITE2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA2
UNIVERSITAET ULM2
UNIVERSITAET ZUERICH2
UNIVERSITE DE NANTES2
UNIVERSITY OF BERGEN2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ALCIMED1
ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA1
ASTELLAS PHARMA EUROPE B V1
AVANTEA1
AZIENDA OSPEDALIERA DI PADOVA1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
AZIENDA OSPEDALIEROUNIVERSITARIA ANNA MEYER1
BG KLINIKUM BERGMANNSTROST HALLE GGMBH1
BIG DATA SANTE1
BIOMATLANTE SAS1
BIOMAX INFORMATICS1
BRISTOL MYERS SQUIBB INTERNATIONAL CORPORATION1
CELL THERAPY CATAPULT LIMITED1
CELLOGIC1
CELLTREND GESELLSCHAFT MIT BESCHRANKTER HAFTUNG1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CERNER FRANCE1
CITOSPIN SL1
CLINIT1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
DIGESTIVE CANCERS EUROPE DICE1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EFFIMUNE SAS1
ELECTRO SCIENTIFIC INDUSTRIES EUROPE1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION1
FINOVATIS1
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO1
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE1
FUNDACIO DE RECERCA CLINIC BARCELONAINSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
GATC BIOTECH1
GENOME IDENTIFICATION DIAGNOSTICS1
GLASGOW CALEDONIAN UNIVERSITY1
GOETEBORGS UNIVERSITET1
HLA ET MEDECINE1
HOPITAL UNIVERSTAIRE DE TOURS1
HOSPICES CANTONAUX CHUV1
HOSPICES CIVILS DE LYON1
I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO1
IMMUNOTECH SAS1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOVATION ACTA1
INSERM TRANSFERT1
INSTITUT DE TERAPIA REGENERATIVA TISULAR SL1
INSTITUT KLINICKE A EXPERIMENTALNI MEDICINY1
INSTITUT STRAUMANN1
INSTITUT UNIV DE CIENCIA I TECNOLOGIA S A1
INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL EPE1
ISTITUTO ORTOPEDICO RIZZOLI1
KITOZYME1
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS1
LOUGHBOROUGH UNIVERSITY1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MILENIA BIOTEC1
MILTENYI BIOTEC1
MIMETIS BIOMATERIALS SL1
MIND THE BYTE SL1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN1
NEUMEDICINES INC1
NOVADISCOVERY SAS1
OXFORD IMMUNOTEC LIMITED1
PHARMATCHING1
SERVICIO MADRILENO DE SALUD1
SOCIEDADE BENEFICENTE ISRAELITA BRASILEIRA HOSPITAL ALBERT EINSTEIN1
SOCIETE EUROPEENNE DE CARDIOLOGIE1
SORLANDET SYKEHUS HF1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
STICHTING RADBOUD UNIVERSITEIT1
STRATEJAI1
SYDDANSK UNIVERSITET1
TEL AVIV UNIVERSITY1
TEVA PHARMACEUTICALS EUROPE BV1

Constancy:

Total number of partners: 162
Partner loyalty:
Frequent Partner: (> 2 projects): 25
Rare Partner: 137
Frequent / Rare Partner Ratio: 0.18

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01An Artificially Intelligent Diagnostic Assistant for gastric inflammation AIDAparticipant6.334.80415
2020-01-01Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia HAP2coordinator9.996.35012
2019-01-01Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials RESHAPEparticipant13.137.39610
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54613
2018-01-01Personalised maxillofacial bone regeneration MAXIBONEparticipant5.949.66512
2017-01-01REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy RESPINEparticipant5.555.83615
2015-05-01A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease BETA3_LVHparticipant5.425.11312
2013-09-01Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINKparticipant5.996.97113
2012-11-01Personalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation BIO-DRIMparticipant5.989.00017
2012-11-01Systems prediction of Chronic Lung Allograft Dysfunction SYSCLADparticipant2.999.1529
2012-01-01Tolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway TRIADparticipant2.959.5907
2010-11-01A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation THE ONE STUDYparticipant10.836.20116
2010-01-01Regenerating Bone defects using New biomedical Engineering approaches REBORNEparticipant11.935.34024

Alias institution names:

  • CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES